Skip to main content
. 2015 May 7;10(5):e0126319. doi: 10.1371/journal.pone.0126319

Fig 8. Subcellular localization of ESE3 in EC9706 after treatment by immunofluorescence analysis.

Fig 8

(A), (B), (C), (D) and (E) indicate subcellular localization of ESE3 after treatment by leptomycin B, actinomycin D, sphinganine (pKC inhibitor), SB202190 (pk38 MAPK inhibitor) and TBCA (CK II inhibitor), respectively. N indicates nuclear localization, C indicates cytoplasmic localization, and N/C indicates nuclear/cytoplasmic localization (equal distribution or uncertain localization).